In the BioHarmony Drug Report Database

"Preview" Icon

Phenoxybenzamine

Dibenzyline (phenoxybenzamine) is a small molecule pharmaceutical. Phenoxybenzamine was first approved as Dibenzyline on 1982-01-01. It is used to treat malignant hypertension, pheochromocytoma, urinary bladder neck obstruction, and urinary incontinence in the USA. The pharmaceutical is active against alpha-2B adrenergic receptor.

 

Trade Name

 

Dibenzyline
 

Common Name

 

phenoxybenzamine
 

ChEMBL ID

 

CHEMBL753
 

Indication

 

malignant hypertension, pheochromocytoma, urinary bladder neck obstruction, urinary incontinence
 

Drug Class

 

Image (chem structure or protein)

Phenoxybenzamine structure rendering